The Old Guard of Plastic Surgery Marketing.

Retro pop-art editorial illustration of a vintage industrial stamping press producing a long line of identical framed surgeon portraits on conveyor belts, in the visual style of 1970s editorial illustration

The plastic surgery web design industry has a small problem and a large problem.

The small problem is that most of the websites in the field look the same. The large problem is that this is not an accident. It is the visible output of a market structure dominated by a handful of legacy marketing companies that, between them, have produced the bulk of plastic surgery websites for the past decade and a half. The convergence is not a coincidence. It is a feature.

For years, the polite thing to do has been to gesture at the problem indirectly. To complain about "templates" or "WordPress sites" without naming the firms producing them. The companies responsible have benefited from this politeness, because the absence of named criticism allowed the convergence to look like a natural state of the industry rather than the consequence of specific business decisions made by specific firms.

It is time to be less polite.

This post is about the legacy companies that have shaped, and continue to shape, what plastic surgery websites look like in America. It names them. It describes what they actually do, how they actually operate, and why the field as a whole has settled for what they produce. The convergence in this category is not anonymous. Specific firms, making specific business decisions, produce specific patterns. Treating those patterns as a vague feature of "the industry" rather than the visible output of identifiable companies has shielded the firms responsible for over a decade. It is no longer useful.

I. The Open Secret

Every plastic surgery practice in America gets pitched by the same handful of companies. The names recur. The contracts look the same. The pitch decks have the same slides in the same order, presented by salespeople who use the same phrases the way airline pilots read from a flight checklist. "Best-in-class SEO." "Conversion-optimized layouts." "Proven across hundreds of practices." "Built by people who understand your specialty."

The pitch is so consistent that when you talk to surgeons about it, they tend to describe the experience identically: a friendly call, a polished mockup, a multi-year contract, and then nothing changes. The website goes live. It looks fine. The leads stay flat. And every month for the next two, three, four years, an invoice arrives.

The plastic surgery web design industry has converged on a small group of legacy companies that produce most of the websites in the field. Studio III. Rosemont Media. Plastic Surgery Studios. NKP Medical. Influx Marketing. A few others around the edges. Different brand names, different sales decks, different cities. And websites that, when laid side by side, are difficult to tell apart.

This is the open secret of the industry. Every surgeon who has been in practice long enough has noticed it. Almost nobody talks about it publicly. The companies producing the work have no incentive to acknowledge it. The surgeons paying for it do not want to look like they made a bad decision. So the convergence continues, year over year, and the field as a whole gets stuck.

II. The Names

Plastic Surgery Studios has been operating since 1999, longer than any other firm in this list. They are family-owned and focused exclusively on aesthetic medicine. By their own account they have served thousands of plastic surgery, dermatology, and cosmetic dental practices. Their websites are built on WordPress, and they are open about it; they argue WordPress is "easy to manage," has "over 10,000 plugins," and is "Google-friendly." It is, for what it is. The problem is that "what it is" caps the experience at a level that no longer matches what discerning patients expect from a premium digital product.

Studio III (also branded as Studio 3 Marketing) is one of the larger firms in the category, with offices in Los Angeles, Austin, and Tampa and a stated team of over 190 employees. They have, to their credit, moved off WordPress entirely; their websites are built on DatoCMS, a modern headless CMS used by companies like Nike, Verizon, and LinkedIn. That is genuinely unusual in plastic surgery marketing. But the platform shift has not eliminated the deeper template problem. Studio III's work is template in a more subtle and more interesting sense than fill-in-the-blanks. The model is closer to: here are these primitives, change the colors and the styles and the fonts and you are done. Two of their sites do not look pixel-identical. But the structural skeleton underneath is the same, and the skeleton is the part the patient feels. Patients do not register the CMS. They register the architectural sameness across practices, and they read it, accurately, as templated.

Rosemont Media operates a boutique exclusivity model: one practice per specialty per geographic area. They market their work as "100% custom," "no templates," "no cut corners." Their websites run on WordPress. The marketing claim and the technology choice are not strictly contradictory; you can build technically custom WordPress sites. But in practice, their portfolio shares substantial structural DNA, and a patient looking at a Rosemont site in one city would have a hard time distinguishing it from a Rosemont site three states away.

NKP Medical has been operating in medical marketing for nearly two decades, serving hundreds of plastic surgeons alongside cosmetic dentists, dermatologists, and med spas. The breadth is the problem. Their plastic surgery work shares architectural DNA with their dental work, and the dental work shares it with the dermatology work. Whatever advantages cross-specialty experience confers, plastic-surgery-specific patient psychology is harder to encode when the production system has to ship a cosmetic dental site this week and an aesthetic surgery site next.

Influx Marketing rounds out the list. They build custom websites for medical, legal, financial, and home-services practices, with plastic surgery as a meaningful vertical. Their pitch is design-led and their work generally sits above the floor for the category. But the same scale dynamics apply, and their plastic surgery portfolio, viewed across many practices, tends toward the same architectural patterns that define the field as a whole.

These companies are not the only ones in the space. There is a long tail of smaller agencies producing similar work at similar quality levels. But the five named above account for an outsized share of the visible plastic surgery web landscape, and the patterns visible in their work are the patterns that have come to define the category as a whole.

III. The Template Underneath

Before we get to the part that actually explains the model, the visible layer deserves a brief accounting. The convergence is real, and it shows up in the source. Most of these companies build on WordPress; Plastic Surgery Studios and Rosemont have publicly confirmed it. A theme they have customized internally and reuse across clients. A stack of plugins for the form builder, the gallery system, the SEO module, the cookie banner, the chat widget. A Core Web Vitals score that, on mobile, ranges from "mediocre" to "concerning" depending on how aggressively the practice has layered carousels and video embeds on top.

A few firms have moved past WordPress. Studio III's stack is built on DatoCMS, a modern headless CMS used by some of the largest brands on the internet. That is a real engineering improvement, and it would be unfair to pretend otherwise. But the platform shift has not eliminated the deeper template problem, because the template problem is not really a platform problem. The model is: here are these primitives, change the colors and the styles and the fonts and you are done. Two sites do not look pixel-identical. The structural skeleton underneath them is the same, and the skeleton is the part the patient feels.

This is the layer surgeons can compare side by side. It is the layer that gets the most attention because it is the layer that is visible. It is also not the layer that explains the model. The design issue is a symptom. The grift is somewhere else.

IV. The Autopay Model

The legacy plastic surgery marketing companies are not, fundamentally, design firms with a recurring revenue feature attached. They are recurring-revenue businesses that happen to ship a website at the start of the engagement. The website is the loss leader. The contract is the product.

Here is how the model actually works. A new client is sold a six-figure annual relationship: a build fee, a monthly retainer, a multi-year minimum. The first ninety days are intensive. Kickoff calls. A handful of strategy meetings. A polished mockup. A launch. Everyone is engaged. The website ships. The agency invoices monthly from that point forward, often by automatic bank draft, for hosting, ongoing SEO, content updates, and support.

This is the moment the model is engineered around. The surgeon paid attention during the build. The surgeon is paying less attention now. The agency knows this, and is structurally optimized for it. From this point forward, the agency's most profitable customer is the one who forgets they exist.

Because in the absence of the surgeon's attention, the work that actually requires effort, the work that was promised in the pitch, quietly does not happen.

Consider what "ongoing SEO" tends to consist of, in practice, at a legacy firm:

A monthly automated dashboard pulling traffic numbers from Google Analytics, formatted to look like an analyst built it. Citations on directory sites of dubious authority. Minor metadata tweaks, sometimes generated en masse and applied across the firm's whole client portfolio. Periodic content updates that are paraphrased from competitor sites or generated through AI tooling and dropped onto procedure pages with minimal review. Backlink acquisition through link-exchange networks rather than earned through real PR. A quarterly "strategy" call that mostly recaps the dashboard.

Now consider what real SEO for a plastic surgery practice in 2026 actually requires:

Original content authored or directed by the surgeon, reflecting their specific procedures, philosophy, and patient outcomes. Procedure-specific schema markup that AI answer engines and Google can parse for entity-rich plastic surgery results. Genuinely earned media coverage and authoritative backlinks from publications that actually matter in the aesthetic medicine ecosystem. Technical optimization that survives a real Lighthouse audit on mobile, not a vendor-supplied dashboard graded by its own author. Quarterly research into what patients in the practice's market are actually searching for, and content responses to those searches before competitors spot the same opportunity.

The first list is cheap to produce at scale, generates a plausible monthly report, and does almost nothing for the practice's real search position. The second list is expensive, requires actual human attention per practice per month, and is exactly what most legacy firms do not do.

The reason the legacy firms can survive in this state is that the reports look the same either way. The surgeon receives "30% increase in impressions this quarter," or "eight new backlinks acquired," or "three procedure pages updated for keyword optimization," and reasonably assumes the work happened the way they imagined it. Patient inquiries move slightly, or do not move at all. The surgeon is busy. The autopay continues. The agency moves on to onboarding the next surgeon.

This is the part of the model that does not show up in the marketing. It is also the part that explains everything else. Why the design is templated: because design is a one-time cost the surgeon notices, and templates ship faster. Why the websites converge: because the firm is solving for "launched" not "exceptional." Why surgeons feel like the work degrades over time: because it does. Why exits are hostile: because the entire model depends on the surgeon not exiting.

And the exit, when the surgeon finally tries to make it, has been engineered to be costly. Contracts have early-termination clauses. Domain ownership is sometimes ambiguous. The practice's content, photography, and historical SEO equity may be partially captive to the agency's systems. The practical effect is that even surgeons who know they should leave often do not, because the cost of leaving feels worse than the cost of staying.

This is why these companies remain dominant despite producing what many thoughtful surgeons quietly know is mediocre work. They are not winning on output quality. They are not even, really, trying to. They are winning on autopay and switching cost. The legacy plastic surgery marketing companies are, in the cleanest possible framing, optimized to extract recurring revenue from busy people who do not have time to audit them.

V. What the Surgeons Tell Us

When you talk to plastic surgeons about their experience with these companies, the autopay model is rarely the way they describe what is wrong. They do not have language for it. What they have is a set of recurring qualitative observations, and the observations line up unnervingly well across surgeons in different cities, at different career stages, working in different specialties.

The first is that the work feels indistinguishable from the rest of the firm's portfolio. Surgeons recognize their own site in their competitor's site. They notice the same headlines, the same procedure-page templates, the same gallery carousels, the same testimonial layouts. The "custom" promise of the sales pitch dissolves into the lived experience of seeing your practice represented by something that could just as easily be representing the practice down the street.

The second is that the relationship goes quiet after launch. Surgeons describe being told they would have a dedicated account manager who would proactively optimize their site, only to find that after the launch, communication slows to a trickle. Updates take weeks. Strategic recommendations stop appearing. The "ongoing partnership" quietly reverts to a transactional support inbox. This is the autopay model showing up in the surgeon's inbox; they did not know that was the name for it, but they recognize the shape.

The third is the sense of being trapped. Surgeons often describe knowing the website is underperforming, knowing they should switch, and feeling unable to. The contract, the domain, the content, the implied disruption to existing rankings. All of it adds up to friction that exceeds their available time and attention to address. So they stay, and the underperformance compounds.

The fourth is the most subtle. Surgeons describe a slow, dawning realization that the sales pitch they bought into was, in important respects, fictional. They were sold "premium" and received average. They were sold "conversion-optimized" and received generic. They were sold a "partnership" and received a vendor. They were sold "ongoing SEO" and received a monthly dashboard. By the time they understand the gap, they are usually two or three years into a contract, and the question is no longer whether the relationship is producing what they hoped. It is whether they have the energy to fight for an exit.

These observations are not isolated. They recur, almost word for word, across the field. The pattern is the pattern.

VI. Why It Persists

If the work is mediocre and the surgeons know it, why does this market structure persist?

Three reasons.

First, plastic surgeons are extremely busy people. Their attention is mostly directed at clinical work, training, and the operational complexity of running a surgical practice. The website is, for most surgeons, a thing they think about for a few weeks every five years and then largely ignore. The legacy marketing companies have correctly identified this and built businesses optimized around it. They do not need to produce excellent work. They need to produce work that is good enough that the surgeon does not have to think about it for another five years.

Second, the surgeon's information environment is largely controlled by these same companies. They sponsor industry conferences. They advertise in trade publications. They cultivate referral relationships with consultants and coaches who recommend them by default. A surgeon trying to evaluate the field finds themselves looking at a landscape where most of the visible voices are either current customers or current vendors, neither of which has an incentive to be honest about the alternatives.

Third, and most importantly, there has historically not been a credible alternative. For a long time, the choice facing a plastic surgeon has been "use one of the legacy companies" or "hire a generic web design firm with no plastic-surgery-specific experience." Neither option was attractive. The legacy firms produced template work but at least understood the category. The generic firms produced sometimes-better work but missed the specifics of patient psychology, the regulatory environment, and the operational realities of a surgical practice. So most surgeons defaulted to the legacy firms, accepting the template ceiling as the cost of working with someone who knew the field.

That third reason is the one that has begun to change.

VII. The Reckoning

What is happening now is the appearance of a third option: a technology-first studio that combines the category expertise of the legacy firms with the engineering, design, and content quality of the best general-purpose digital agencies, and pairs that with a business model that is not built on hoping the surgeon forgets they exist. AestheticOS is that studio. There is not a second one. The field has been waiting for it for over a decade.

This shift will not happen overnight. The legacy companies have entrenched relationships, multi-year contracts, and considerable resources. They will continue to dominate the bottom and middle of the market for some time. But the surgeons whose practices depend on attracting the most discerning patients, the ones for whom the website is not a checkbox but a primary marketing asset, will increasingly look outside the old guard. Once a few practices in a city move to a genuinely modern site, the comparison becomes obvious. The patient lands on three websites. Two of them feel like 2014. One of them feels like 2026. The decision is made before the patient consciously evaluates anything.

If you are a surgeon currently with one of the legacy companies, the relevant questions are economic. Is the site producing what your practice actually needs in 2026 and beyond? Does it load fast enough? Does it rank for the queries that matter? Do the patients who land on it convert at a rate that justifies the spend? Does the experience represent the standard of your practice, or merely the average of your category? Is the monthly invoice buying any work, or is it buying a dashboard?

The answers are knowable. The honest answer, for most practices currently with Studio III, Rosemont Media, Plastic Surgery Studios, NKP Medical, or Influx Marketing, is that the website is leaving meaningful patient acquisition on the table month after month, and that the monthly invoice is buying very little of what it is supposed to be buying. The opportunity cost is real. The wasted spend is real. Both compound.

The legacy era is not over. But it is no longer the only option, and the surgeons who recognize this first will be the ones who shape what the next decade of plastic surgery marketing looks like.

For the broader thesis behind this argument, read The Modern Plastic Surgery Website. For why the underlying platform matters more than the surface design, read Why WordPress and Squarespace Limit Your Plastic Surgery Website.

No plastic surgery website yet? Perfect. Already have one? Let's make it unforgettable.

We design from scratch and ship quickly without compromising polish.

Start Your Project